Education
About Us
Working with TipRanks
Follow Us
Philogen SpA (IT:PHIL)
:PHIL
PHIL Stock Chart & Stats
Day’s Range― - ―
52-Week Range€16.50 - €21.90
Previous CloseN/A
Volume5.57K
Average Volume (3M)8.63K
Market Cap
€573.16M
Enterprise ValueN/A
Total Cash (Recent Filing)€3.56M
Total Debt (Recent Filing)€13.16M
Price to Earnings (P/E)―
Beta0.12
Next Earnings
May 06, 2025EPS Estimate
6.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding29,242,860
10 Day Avg. Volume12,099
30 Day Avg. Volume8,632
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)25.77
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€25.00Price Target Upside25.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Philogen SpA News
PremiumCompany Announcements
Philogen Updates Share Buyback Program, Strengthening Market Position
PremiumCompany Announcements
Philogen Publishes Shareholders’ Meeting Documentation for April 2025
PremiumCompany Announcements
Philogen S.p.A. Achieves Record Profits and Advances Cancer Therapy Pipeline
PremiumCompany Announcements
Philogen S.p.A. Updates on Share Buyback Program
PremiumCompany Announcements
Philogen Updates Share Buyback Program with Recent Purchases
PremiumCompany Announcements
Philogen S.p.A. Updates on Share Buyback ProgramPremiumCompany Announcements
Philogen Advances Share Buyback Program---
Bulls Say, Bears Say
Bulls Say
Financial GrowthPhilogen expects to triple its revenues as a result of the partnership agreement with Sun Pharma, highlighting strong financial growth prospects.
Partnership And CollaborationPhilogen has extended its partnership with Sun Pharma to include Fibromun, enhancing its global commercialization prospects.
Stock OutlookPhilogen SpA's stock shows a potential upside to its price target of 32.6%.
Bears Say
Dividend YieldThe dividend yield is expected to remain at 0.0%, which might be a concern for investors seeking income from dividends.
Economic AgreementThe agreement includes a 45(PHIL):55(Sun) split in post-commercialisation economic.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
―
Mutual Funds
― Other Institutional Investors
99.87% Public Companies and
Individual Investors
PHIL FAQ
What was Philogen SpA’s price range in the past 12 months?
Philogen SpA lowest stock price was €16.50 and its highest was €21.90 in the past 12 months.
What is Philogen SpA’s market cap?
Philogen SpA’s market cap is €573.16M.
When is Philogen SpA’s upcoming earnings report date?
Philogen SpA’s upcoming earnings report date is May 06, 2025 which is in 34 days.
How were Philogen SpA’s earnings last quarter?
Currently, no data Available
Is Philogen SpA overvalued?
According to Wall Street analysts Philogen SpA’s price is currently Undervalued.
Does Philogen SpA pay dividends?
Philogen SpA does not currently pay dividends.
What is Philogen SpA’s EPS estimate?
Philogen SpA’s EPS estimate is 6.15.
How many shares outstanding does Philogen SpA have?
Philogen SpA has 29,242,860 shares outstanding.
What happened to Philogen SpA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Philogen SpA?
Currently, no hedge funds are holding shares in IT:PHIL
---
Company Description
Philogen SpA
Philogen Spa is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others.
---
PHIL Stock 12 Month Forecast
Average Price Target
€25.00
▲(25.94% Upside)
Technical Analysis
BFF Bank SpA
―
DiaSorin S.p.A.
―
ENI S.p.A.
―
Gruppo Mutuionline SpA
―
Prysmian SpA
―
Best Analysts Covering PHIL
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-1.10%
reiterated a buy rating 5 days ago
Copying Clémence Thiers's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -1.10% per trade.
---